Update on laboratory testing and hemostasis assessment in patients receiving direct oral anticoagulants (DOACs)
Direct oral anticoagulants (DOACs) have been established and already registered worldwide for clinical use. Contrary to vitamin K antagonists, their mode of action is based on the direct inhibition of the single coagulation enzymes factor Xa or IIa. Even though the DOACs do not require routine labor...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2021-12-01
|
| Series: | Thrombosis Update |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2666572721000535 |